Synergistic Antithrombosis Induced by Plasminogen Activator and Kinexins
碩士 === 長庚大學 === 生物醫學研究所 === 105 === Clinical thrombolytic therapy with recombinant tissue plasminogen activator (rtPA) is associated with significant limitations, including resistance to recanalization, prolonged time to achieve reperfusion, acute thrombotic reocclusion in a high percentage of treat...
Main Authors: | Chao Wei Huang, 黃昭瑋 |
---|---|
Other Authors: | Y. H. Ma |
Format: | Others |
Language: | zh-TW |
Published: |
2016
|
Online Access: | http://ndltd.ncl.edu.tw/handle/a77txm |
Similar Items
-
Natural Products for Antithrombosis
by: Cen Chen, et al.
Published: (2015-01-01) -
The Complementary and Alternative Medicine for Antithrombosis
by: Feng-Qing Yang, et al.
Published: (2015-01-01) -
Studies on New Activities of Enantiomers of 2-(2-Hydroxypropanamido) Benzoic Acid: Antiplatelet Aggregation and Antithrombosis.
by: Qili Zhang, et al.
Published: (2017-01-01) -
Antiplatelet Aggregation and Antithrombosis Efficiency of Peptides in the Snake Venom of Deinagkistrodon acutus: Isolation, Identification, and Evaluation
by: Bin Ding, et al.
Published: (2015-01-01) -
Effect of alteplase thrombolysis sequenced by low molecular heparin calcium antithrombosis on the neurological function and serum cytokines in patients with cerebral infarction
by: Yi-Ping Dan
Published: (2017-04-01)